Brief: Chemometec Q3 EBITDA DKK 43.1 Million
08/05/2024 17:20
May 08 (Reuters) - Chemometec Q3 EBITDA margin 44%. * outlook FY EBITDA DKK 185-200 million
Recent news on ChemoMetec A/S
See all newsDenmark's Chemometec Q1 revenue rises 28% on instrument sales
Brief: Chemometec Q1 EBITDA DKK 100.3 Million
Denmark's ChemoMetec lifts FY outlook on strong instrument demand, lower costs
Brief: Chemometec Raises 2026/27 EBITDA Guidance To DKK 335-360 Million
Brief: Chemometec A/S Says Board Initiates Share Buy-Back Based On AGM Authorisation